The Federal Prosecutor’s Office has suspended a criminal investigation against a former parliamentarian suspected of corruption over lobbying efforts by Kazakhstan.
This content was published on
1 minute
swissinfo.ch/ug
The decision, which is subject to appeal, was announced by the Neue Zürcher Zeitung newspaper on Tuesday. The justice authorities have refused to give details on the case.
The inquiry was opened in April last year against Christian Miesch, a former representative of the Swiss People’s Party, and a lobbyist – and former Swiss ambassador – Thomas Borer. Both cases were reportedly dropped based on a decision taken earlier this month.
Miesch was suspected of accepting money – CHF4,635 ($4,637) – in return for trying to serve the interests of Kazakhstan in parliament and lost his parliamentary immunity. He has denied any wrongdoing but stepped down in 2015.
Initially, two other parliamentarians were also involved in the case, but they did not have their immunity from prosecution lifted.
The media coverage of the affair has come in for criticism by one of the accused.
More
More
MPs are the biggest lobbyists in Swiss parliament
This content was published on
Parliamentarians are increasingly, and more aggressively, representing particular interests. It’s a cultural change in the legislature.
This content was published on
The UN Human Rights Council approved the launch of this mechanism in Geneva on Friday, to be followed by an International Commission of Inquiry.
More than 100 wolves shot in Switzerland last year
This content was published on
Swiss hunters legally killed 101 wolves between February 1, 2024, and the end of January 2025. A further six died in accidents or from natural causes.
Swiss health office turns to Bluesky against backdrop of US censorship
This content was published on
The Swiss Federal Office of Public Health (FOPH) has joined the Bluesky social network, while US President Donald Trump works with X owner Elon Musk to censor content on official US websites.
Biotech company BioVersys is first Swiss IPO of 2025
This content was published on
The Basel-based biotech company BioVersys made the first initial public offering (IPO) of the year in Switzerland on Friday.
Much more spent on Swiss motorway vote campaigns than budgeted
This content was published on
Opponents and supporters of motorway expansion spent over CHF10 million ($11 million) on their campaigns, around a third more than announced in November.
Swiss researchers monitor animal populations with AI microphone
This content was published on
Researchers in Lausanne are using an intelligent microphone to make the animal world audible. The microphone automatically records animal sounds over large areas and analyses them using AI.
Three employees of Swiss aid organisation killed in DRC
This content was published on
Three employees of the Swiss Protestant Reformed Church (Heks) have been killed in an attack in the Democratic Republic of Congo (DRC). They were on a humanitarian mission in the crisis region.
This content was published on
All our waters today are pure at source," Muriel Lienau, general manager of Nestlé Waters, told AFP after press revelations.
Switzerland concerned about impact of US withdrawal from WHO
This content was published on
Switzerland has expressed concern about the loss of American experts and the freezing of contracts due to the announced withdrawal of the US from the World Health Organization (WHO).
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Parliamentary immunity lifted in alleged corruption case
This content was published on
A former Swiss parliamentarian has been stripped of his immunity, paving the way for a legal investigation into corruption allegations.
This content was published on
Several recent scandals have highlighted efforts to influence Swiss parliamentarians by the regime of president Nursultan Nazarbayev of Kazakhstan.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.